title: Transfusion immunomodulation--the case for leukoreduced and (perhaps) washed transfusions.
abstract: During the last three decades, a growing body of clinical, basic science and animal model data has demonstrated that blood transfusions have important effects on the immune system. These effects include: dysregulation of inflammation and innate immunity leading to susceptibility to microbial infection, down-regulation of cellular (T and NK cell) host defenses against tumors, and enhanced B cell function that leads to alloimmunization to blood group, histocompatibility and other transfused antigens. Furthermore, transfusions alter the balance between hemostasis and thrombosis through inflammation, nitric oxide scavenging, altered rheologic properties of the blood, immune complex formation and, no doubt, several mechanisms not yet elucidated. The net effects are rarely beneficial to patients, unless they are in imminent danger of death due to exsanguination or life threatening anemia. These findings have led to appeals for more conservative transfusion practice, buttressed by randomized trials showing that patients do not benefit from aggressive transfusion practices. At the risk of hyperbole, one might suggest that if the 18th and 19th centuries were characterized by physicians unwittingly harming patients through venesection and bleeding, the 20th century was characterized by physicians unwittingly harming patients through current transfusion practices. In addition to the movement to more parsimonious use of blood transfusions, an effort has been made to reduce the toxic effects of blood transfusions through modifications such as leukoreduction and saline washing. More recently, there is early evidence that reducing the storage period of red cells transfused might be a strategy for minimizing adverse outcomes such as infection, thrombosis, organ failure and mortality in critically ill patients particularly at risk for these hypothesized effects. The present review will focus on two approaches, leukoreduction and saline washing, as means to reduce adverse transfusion outcomes.
authors.affiliation: Department of Microbiology and Immunology, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA.
authors.forename: Katie L
authors.initials: KL
authors.lastname: Lannan
authors.forename: Julie
authors.initials: J
authors.lastname: Sahler
authors.forename: Sherry L
authors.initials: SL
authors.lastname: Spinelli
authors.forename: Richard P
authors.initials: RP
authors.lastname: Phipps
authors.forename: Neil
authors.initials: N
authors.lastname: Blumberg
mesh_terms: D001771:Blood Banks; D016638:Critical Illness / Q000628:therapy*; D015925:Cryopreservation; D016238:Cytapheresis / Q000191:economics / Q000379:methods / Q000706:statistics & numerical data*; D006801:Humans; D007107:Immune System; D056747:Immunomodulation; D047589:Leukocyte Reduction Procedures / Q000191:economics / Q000379:methods / Q000706:statistics & numerical data*; D016032:Randomized Controlled Trials as Topic; D012189:Retrospective Studies; D012307:Risk Factors; D065227:Transfusion Reaction